PharmaCielo Ltd. , the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S. , and Ease Labs...
PharmaCielo Ltd. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported revenue was CAD 0.159539 million compared to CAD 2.12...
PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., announced its financial results on Tuesday for the second quarter ended June 30, 2023.
All figures in Canadian dollars ($) unless otherwise specified
Toronto, Ontario and Rionegro, Colombia - August 29, 2023 (Newsfile Corp.) (Investorideas.com Ne...
As Benzinga Cannabis Capital Conference returns to Chicago this Sept 27-28 for its 17th edition, gathering top CEOs, investors and leaders in the cannabis
PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF) the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., today announced financial results for the fir
PharmaCielo Ltd. (OTCQX: PCLOF) (TSXV:PCLO) released financial results for the fourth quarter and year ended December 31, 2022, revealing total revenue of CA$5.3 million ($3.9 million), an increase of 173% compared to CA$1.9 million in FY 2021.
PharmaCielo Ltd. (OTCQX: PCLOF) (TSXV:PCLO) provided a corporate update, regarding progress against the efficiency initiatives it began to implement in mid-2021, which are designed to accelerate the company's path to profitability.
PharmaCielo Ltd. (TSXV:PCLO) (OTCQX: PCLOF), released financial results for the third quarter ended September 30, 2022, revealing total revenue of CA$475,323 ($348,000), a 2% decrease compared to CA$485,165 in Q3 2021.
2020 was a year of divergence in markets. Some industries, like health care and e-commerce, benefited greatly from the effects of the pandemic. Others, like ...